Nektar Therapeutics is transforming its business model, shifting from PEGylation drug delivery to innovative immunotherapy and autoimmune treatments. This strategic evolution marks a new chapter in its biotech journey toward sustainable growth and medical
Kellogg’s split into Kellanova and WK Kellogg Co in 2023 marks a new era for the 117-year-old brand. Discover how the iconic cereal company evolved into two focused businesses targeting global snack growth and North American breakfast revival.